Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-005566 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,052
Total Value
$52,322.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: EVP Chief Commercial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 2,052 | $25.50 | $52,322.72 | 148,865 | Direct | โ | View Details |